News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

SIDMAP: Discovery of Early Metabolic Marker for Drug Toxicity on the Liver to Be Announced at Metabolic Society's 3rd Annual Conference in Manchester, U.K., June 11-14, 2007


6/7/2007 2:10:24 PM

LOS ANGELES--(BUSINESS WIRE)--SiDMAP, LLC, a provider of metabolic profiling and biomarker development services to the pharmaceutical and biotechnology industries, announced today the discovery of an early metabolic marker for liver toxicity linked to the drug valproic acid, which is used in the treatment of epilepsy, bi-polar disease, and other disorders of the central nervous system. The new biomarker was discovered jointly by SiDMAP scientists and their scientific collaborators at the U.S. Food and Drug Administration (FDA).

Read at press release


comments powered by Disqus
SIDMAP
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES